IMA · TickerCove

IMAImageneBio IncHealthcare · Biotechnologyas of 2026-09-16

Horizon

Issued 2026-09-16 at $4.93 · now $4.93 (2026-09-16, +0.0% since)

Based on its own history, a month from the 2026-09-16 close, IMA has typically landed between $3.36 and $6.59 — a range of −31.8% to +33.7% from the issuance price $4.93.

Range of outcomes in historically similar periods — not a price prediction. Ranges are scored publicly on /methodology.

Actual close
Typical path (median)
Middle 50% of outcomes
90% range

1,353 overlapping 1 month windows · 2021-03-26 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).

The cone is anchored at the 2026-09-16 issuance close ($4.93) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.

52-week range$4.93 · 9% of range

$4.55 low$8.79 high

Trailing 52 weeks to 2026-09-16 — factual context, not a signal.

Base rate up · monthiClimatology base rate that a US-listed stock rises over a month, with its 90% CI and ≈1,408 effective observations. Not a call on this stock — we have no evidence its odds differ.

53.9%

90% CI 51.7%–56.1%

Distribution · month iiThe price-anchored range: typical move (median), and the p90 downside/upside — 90% of similar periods stayed inside these. Ranges, not a prediction of direction.

−3.8%

typical move · IQR 19.5%

−31.8%worst (p90)+33.7%best (p90)

Insider convictioniOpen-market common-stock purchases by company insiders in the last 90 days (grants and option exercises excluded). Historical tendency, not advice — detail below.

conviction buys

0 open-market sales

Congress disclosuresiRecent disclosed congressional trades for this company. Purchase clusters (≥2 members buying within 90 days) historically preceded a modestly higher forward return (+32 bp/mo in 2022–2026, +45 bp/mo in 2015–2021) — a descriptive tendency, not a forecast input. Detail below.

0 buys · 0 sells · 0 members

cluster tilt persisted, ~halved after 2021

Where IMA has typically landed a month from the 2026-09-16 close of $4.93 — the range is history, not a prediction.

now $4.93 (+0.0%)
typical $4.74 (-3.8%)
middle 50% $4.26–$5.22
90% range $3.36–$6.59

Actual 1-month windows behind the coneiEvery overlapping 1-month window in this security's own price history was ranked by realized return; shown are the 3 worst and 3 best of 1,353 windows spanning 2021-03-26 to 2026-09-16. Not cherry-picked — these are the extremes of the full sample. Max drop / max rise are the deepest and highest points reached within each window. See /methodology.

Start	Return	Max drop	Max rise
3 worst
2023-10-13	−67.7%	−67.7%	+4.5%
2023-10-16	−66.9%	−67.8%	+4.0%
2023-10-11	−65.2%	−65.2%	+5.0%
3 best
2023-04-05	+102.5%	+0.0%	+102.5%
2023-04-04	+79.4%	+0.0%	+79.4%
2023-04-06	+69.1%	+0.0%	+76.6%

1,353 overlapping windows · 2021-03-26 – 2026-09-16 · not cherry-picked

Seasonality · by month i

iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.

Jan

40%

+1.0%

n=5

Feb

20%

−11.3%

n=5

Mar

−9.0%

n=5

Apr

33%

+3.6%

n=6

May

50%

+2.9%

n=6

Jun

67%

−0.1%

n=6

Jul

50%

−4.9%

n=6

Aug

33%

−2.9%

n=6

Sep

17%

−12.5%

n=6

Oct

20%

−7.7%

n=5

Nov

40%

−13.9%

n=5

Dec

40%

+7.5%

n=5

Up-frequency and average month-over-month return · historical frequency, not a prediction

Reported insider & political trades

Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.

Date	Person	Role	Action	Shares @ price	Value	Ownership Δ	vs S&P 1m	vs S&P 6m	Owned after	Filing
2026-07-17	Lally Robert B	officer	Sale	1,525 @ $5.34	$8K	−2.7% of holding	−0.2%	not yet — horizon still open	55,582	Form 4 · filed 3 days after the trade
2026-07-16	Lally Robert B	officer	Sale	1,671 @ $5.50	$9K	−2.8% of holding	+3.7%	not yet — horizon still open	57,107	Form 4 · filed 4 days after the trade
2026-04-14	ORBIMED ADVISORS LLC	director	Purchase	384,689	—	ownership Δ n/a	−6.2%	not yet — horizon still open	384,689	Form 4 · filed 2 days after the trade
2026-04-14	ORBIMED ADVISORS LLC	director	Purchase	384,689	—	ownership Δ n/a	−6.2%	not yet — horizon still open	384,689	Form 4 · filed 2 days after the trade
2026-04-14	ORBIMED ADVISORS LLC	director	Purchase	336,603	—	ownership Δ n/a	−6.2%	not yet — horizon still open	336,603	Form 4 · filed 2 days after the trade
2026-04-14	ORBIMED ADVISORS LLC	director	Purchase	384,689	—	ownership Δ n/a	−6.2%	not yet — horizon still open	384,689	Form 4 · filed 2 days after the trade
2026-04-14	ORBIMED ADVISORS LLC	director	Purchase	336,603	—	ownership Δ n/a	−6.2%	not yet — horizon still open	336,603	Form 4 · filed 2 days after the trade
2026-04-14	ORBIMED ADVISORS LLC	director	Purchase	336,603	—	ownership Δ n/a	−6.2%	not yet — horizon still open	336,603	Form 4 · filed 2 days after the trade
2026-04-14	Bonita David P	director	Purchase	336,603	—	ownership Δ n/a	−6.2%	not yet — horizon still open	336,603	Form 4 · filed 2 days after the trade
2026-04-14	Bonita David P	director	Purchase	384,689	—	ownership Δ n/a	−6.2%	not yet — horizon still open	384,689	Form 4 · filed 2 days after the trade
2026-04-14	ORBIMED ADVISORS LLC	director	Purchase	384,689	—	ownership Δ n/a	−6.2%	not yet — horizon still open	384,689	Form 4 · filed 2 days after the trade
2026-04-14	Bonita David P	director	Purchase	336,603	—	ownership Δ n/a	−6.2%	not yet — horizon still open	336,603	Form 4 · filed 2 days after the trade
2026-04-14	Bonita David P	director	Purchase	384,689	—	ownership Δ n/a	−6.2%	not yet — horizon still open	384,689	Form 4 · filed 2 days after the trade
2026-04-14	ORBIMED ADVISORS LLC	director	Purchase	336,603	—	ownership Δ n/a	−6.2%	not yet — horizon still open	336,603	Form 4 · filed 2 days after the trade
2025-12-24	SLATTERY JOSEPH P	director	Purchase	16,000 @ $5.99	$96K	ownership Δ n/a	+24.9%	−4.1%	16,000	Form 4 · filed 5 days after the trade
2025-07-25	Stampacchia Otello	director	Purchase	267,556 @ $29.90	$8.0M	+142.8% of holding	−18.4%	−67.9%	454,982	Form 4 · filed 5 days after the trade
2025-07-25	Bonita David P	director	Purchase	83,611 @ $29.90	$2.5M	+40.9% of holding	−18.4%	−67.9%	287,885	Form 4 · filed 5 days after the trade

The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.

57 award / exercise / gift records — not counted as purchases

Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.

Date	Person	Role	Action	Shares	Owned after	Filing
2026-08-14	Yarema Kristin	director	Award / grant	250,000	250,000	Form 4
2026-08-14	Grant-Huerta Yanina	officer	Award / grant	39,000	104,000	Form 4
2026-08-14	Grant-Huerta Yanina	officer	Award / grant	56,000	56,000	Form 4
2026-08-14	Yarema Kristin	director	Award / grant	254,800	493,705	Form 4
2026-08-14	Yarema Kristin	director	Award / grant	137,200	137,200	Form 4
2026-08-14	Grant-Huerta Yanina	officer	Award / grant	65,000	65,000	Form 4
2026-07-25	Yarema Kristin	director	Other acquisition	115,129	0	Form 4
2026-07-25	Yarema Kristin	director	Option exercise	38,376	115,129	Form 4
2026-07-25	Yarema Kristin	director	Other acquisition	115,129	238,905	Form 4
2026-07-25	Yarema Kristin	director	Option exercise	38,376	123,776	Form 4
2026-06-16	SLATTERY JOSEPH P	director	Award / grant	15,600	15,600	Form 4
2026-06-16	Stampacchia Otello	director	Award / grant	15,600	15,600	Form 4
2026-06-16	Wang Jonathan Jian	director	Award / grant	15,600	15,600	Form 4
2026-06-16	Bonita David P	director	Award / grant	15,600	15,600	Form 4
2026-03-16	Yarema Kristin	director	Award / grant	128,100	128,100	Form 4
2026-03-16	Yarema Kristin	director	Award / grant	85,400	85,400	Form 4
2025-12-30	Butler Erin	officer	Award / grant	22,500	25,551	Form 4
2025-12-30	Butler Erin	officer	Award / grant	22,500	22,500	Form 4
2025-12-18	Wang Stephen Hui	director	Award / grant	31,200	31,200	Form 4
2025-12-18	Wang Jonathan Jian	director	Award / grant	31,200	31,200	Form 4
2025-12-18	SLATTERY JOSEPH P	director	Award / grant	31,200	31,200	Form 4
2025-07-28	Marango Jotin	officer	Withheld for tax	4,630	11,146	Form 4
2025-07-28	Yarema Kristin	director	Award / grant	460,515	460,515	Form 4
2025-07-28	Yarema Kristin	director	Award / grant	153,505	153,505	Form 4
2025-07-28	Marango Jotin	officer	Award / grant	15,776	15,776	Form 4
2025-07-28	Marango Jotin	officer	Award / grant	15,776	15,776	Form 4
2025-07-25	Stampacchia Otello	director	Option exercise	17,520	0	Form 4
2025-07-25	Marango Jotin	officer	Disposition	105,000	0	Form 4
2025-07-25	Marango Jotin	officer	Disposition	181,000	0	Form 4
2025-07-25	Marango Jotin	officer	Disposition	397,199	0	Form 4
2025-07-25	Bonita David P	director	Option exercise	17,520	0	Form 4
2025-07-25	Lu Yufang	officer	Award / grant	27,459	27,459	Form 4
2025-07-25	Lu Yufang	officer	Award / grant	4,591	4,591	Form 4
2025-07-25	Wang Jonathan Jian	director	Award / grant	971,173	971,173	Form 4
2025-07-25	Butler Erin	officer	Award / grant	3,051	3,051	Form 4
2025-07-25	Butler Erin	officer	Award / grant	3,813	3,813	Form 4
2025-07-25	Butler Erin	officer	Award / grant	3,051	3,051	Form 4
2025-07-25	Butler Erin	officer	Award / grant	3,813	3,813	Form 4
2025-07-25	Stampacchia Otello	director	Option exercise	379	379	Form 4
2025-07-25	Bonita David P	director	Option exercise	379	379	Form 4

Source: SEC Form 4 filings. Each row links to its original filing.

Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.

Congressional disclosures

No congressional trades disclosed for this company.

Resolves in i

28d remaining

2026-09-173% elapsed2026-10-15

Logged immutably 2026-09-17; scored automatically on 2026-10-15 — no edits, ever.

Earnings & context analysis

These panels are being prepared. They are generated by multiple language models, checked, and stored before display — never written live for a page view. Until a model panel has been generated and reviewed for a company, nothing is shown here, honestly, rather than a placeholder.

Calibration i

Every forecast is logged when made and scored when the month is up. The record is shown from the day it starts — young and honest.

How scoring works →

Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.

Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.

Reported insider & political trades

Congressional disclosures

Seasonality · by month i